NCT01144611 - Efficacy and Safety of Bovine Intestinal Alkaline Phosphatase (bIAP) During Heart Surgery | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions

Inflammation

Interventions

DRUG

bIAP bolus and 8h infusion

intravenous as a bolus of bIAP (bovine intestinal alkaline phosphatase, 1000 IU) just prior to surgery followed by a 40 IU/kg bIAP infusion during the first 8 hours post surgery.

DRUG

placebo bolus and 8h infusion

intravenous as a bolus just prior to surgery followed by an infusion during the first 8 hours post surgery.

Trial Locations (1)

5623 EJ

Catharina Ziekenhuis, Dept. CardioThoracic Surgery, Eindhoven